BuPROPion (Eqv-Wellbutrin SR)

Generic name: Bupropion

Usage of BuPROPion (Eqv-Wellbutrin SR)

Bupropion (Eqv-Wellbutrin SR) is an antidepressant used to treat major depressive disorder and seasonal affective disorder. The Zyban brand of BuPROPion (Eqv-Wellbutrin SR) is used to help people stop smoking by reducing cravings and other withdrawal effects.

BuPROPion (Eqv-Wellbutrin SR) may also be used for purposes not listed in this medication guide.

BuPROPion (Eqv-Wellbutrin SR) side effects

Get emergency medical help if you have signs of an allergic reaction (hives, itching, fever, swollen glands, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, depression, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.

BuPROPion (Eqv-Wellbutrin SR) may cause serious side effects. Call your doctor at once if you have:

  • a seizure (convulsions);
  • confusion, unusual changes in mood or behavior;
  • blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
  • fast or irregular heartbeats; or
  • a manic episode--racing thoughts, increased energy, reckless behavior, feeling extremely happy or irritable, talking more than usual, severe problems with sleep.
  • Common side effects of BuPROPion (Eqv-Wellbutrin SR) may include:

  • dry mouth, sore throat, stuffy nose;
  • ringing in the ears;
  • blurred vision;
  • nausea, vomiting, stomach pain, loss of appetite, constipation;
  • sleep problems (insomnia);
  • tremors, sweating, feeling anxious or nervous;
  • fast heartbeats;
  • confusion, agitation, hostility;
  • rash;
  • weight loss;
  • increased urination;
  • headache, dizziness; or
  • muscle or joint pain.
  • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking BuPROPion (Eqv-Wellbutrin SR)

    You should not take BuPROPion (Eqv-Wellbutrin SR) if you are allergic to it, or if you have:

  • a seizure disorder;
  • an eating disorder such as anorexia or bulimia; or
  • if you have suddenly stopped using alcohol, seizure medication, or a sedative (such as Xanax, Valium, Fiorinal, Klonopin, and others).
  • Do not use an MAO inhibitor within 14 days before or 14 days after you take BuPROPion (Eqv-Wellbutrin SR). A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, and tranylcypromine.

    Do not take BuPROPion (Eqv-Wellbutrin SR) to treat more than one condition at a time. If you take BuPROPion (Eqv-Wellbutrin SR) for depression, do not also take BuPROPion (Eqv-Wellbutrin SR) (Eqv-Wellbutrin SR) to quit smoking.

    BuPROPion (Eqv-Wellbutrin SR) may cause seizures, especially if you have certain medical conditions or use certain drugs. Tell your doctor about all of your medical conditions and the drugs you use.

    Tell your doctor if you have ever had:

  • a head injury, seizures, or brain or spinal cord tumor;
  • narrow-angle glaucoma;
  • heart disease, high blood pressure, or a heart attack;
  • diabetes;
  • kidney or liver disease (especially cirrhosis);
  • depression, bipolar disorder, or other mental illness; or
  • if you drink alcohol.
  • Some young people have thoughts about suicide when first taking an antidepressant. Your doctor will need to check your progress at regular visits. Your family or other caregivers should also be alert to changes in your mood or symptoms.

    Ask your doctor about taking this medicine if you are pregnant. It is not known whether BuPROPion (Eqv-Wellbutrin SR) will harm an unborn baby. However, you may have a relapse of depression if you stop taking your antidepressant. Tell your doctor right away if you become pregnant. Do not start or stop taking BuPROPion (Eqv-Wellbutrin SR) without your doctor's advice.

    If you are pregnant, your name may be listed on a pregnancy registry to track the effects of BuPROPion (Eqv-Wellbutrin SR) on the baby.

    It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

    BuPROPion (Eqv-Wellbutrin SR) is not approved for use by anyone younger than 18 years old.

    How to use BuPROPion (Eqv-Wellbutrin SR)

    Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed. Too much of this medicine can increase your risk of a seizure.

    You may take BuPROPion (Eqv-Wellbutrin SR) with or without food.

    Swallow the extended-release tablet whole and do not crush, chew, or break it.

    You should not change your dose or stop using BuPROPion (Eqv-Wellbutrin SR) suddenly, unless you have a seizure while taking this medicine. Stopping suddenly can cause unpleasant withdrawal symptoms. Ask your doctor how to safely stop using BuPROPion (Eqv-Wellbutrin SR).

    If you take Zyban to help you stop smoking, you may continue to smoke for about 1 week after you start the medicine. Set a date to quit smoking during the first 2 weeks of treatment. Talk to your doctor if you have trouble quitting after taking Zyban for 7 to 12 weeks.

    Your doctor may prescribe a nicotine replacement product (such as patches or gum) to help you stop smoking. Start using the nicotine replacement product on the same day you stop (quit) smoking or using tobacco products.

    Some people taking BuPROPion (Eqv-Wellbutrin SR) (Wellbutrin or Zyban) have had high blood pressure that is severe, especially when also using a nicotine replacement product (patch or gum). Your blood pressure may need to be checked before and during treatment with BuPROPion (Eqv-Wellbutrin SR).

    Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you do not understand these instructions.

    You may have nicotine withdrawal symptoms when you stop smoking, including: increased appetite, weight gain, trouble sleeping, trouble concentrating, slower heart rate, having the urge to smoke, and feeling anxious, restless, depressed, angry, frustrated, or irritated. These symptoms may occur with or without using medication such as Zyban.

    Smoking cessation may also cause new or worsening mental health problems, such as depression.

    This medicine may affect a drug-screening urine test and you may have false results. Tell the laboratory staff that you use BuPROPion (Eqv-Wellbutrin SR).

    Store at room temperature away from moisture, heat, and light.

    Warnings

    You should not take BuPROPion (Eqv-Wellbutrin SR) if you have seizures or an eating disorder, or if you have suddenly stopped using alcohol, seizure medication, or sedatives. If you take Wellbutrin for depression, do not also take Zyban to quit smoking.

    Do not use BuPROPion (Eqv-Wellbutrin SR) within 14 days before or 14 days after you have used an MAO inhibitor, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine.

    Some young people have thoughts about suicide when first taking an antidepressant. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.

    What other drugs will affect BuPROPion (Eqv-Wellbutrin SR)

    You may have a higher risk of seizures if you use certain other medicines while taking BuPROPion (Eqv-Wellbutrin SR).

    Many drugs can affect BuPROPion (Eqv-Wellbutrin SR). This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.

    Popular FAQ

    You may notice an improvement in your sleep, energy and appetite in the first week or two of taking Wellbutrin and this can be an important sign that the drug is working. But, like other antidepressants, improvements in your mood or motivation may take 6 to 8 weeks to develop. Continue reading

    Auvelity worked significantly better than Wellbutrin (bupropion) at relieving symptoms of depression in a small randomized double-blind, parallel trial that lasted for 6 weeks. It also had a faster onset of effect, with improvement in the Montgomery-Åsberg Depression Rating Scale (MADRS) score being observed as early as week 1 and differences being statistically significant by week 2. Continue reading

    Both Auvelity and Wellbutrin are effective for depression but a small RCT (n=80) reported that Auvelity worked significantly better than Wellbutrin and took less time to start working. 43 people prescribed Auvelity experienced an overall decrease in their Montgomery-Åsberg Depression Rating Scale (MADRS) score of 13.7 points after 6 weeks compared to a decrease of 8.8 points in the 37 people prescribed bupropion (least-squares mean difference=-4.9; 95% CI=-3.1, -6.8). Continue reading

    You may notice an improvement in your sleep, energy and appetite in the first week or two of taking Wellbutrin and this can be an important sign that the drug is working. But, like other antidepressants, improvements in your mood or motivation may take 6 to 8 weeks to develop. Continue reading

    Auvelity worked significantly better than Wellbutrin (bupropion) at relieving symptoms of depression in a small randomized double-blind, parallel trial that lasted for 6 weeks. It also had a faster onset of effect, with improvement in the Montgomery-Åsberg Depression Rating Scale (MADRS) score being observed as early as week 1 and differences being statistically significant by week 2. Continue reading

    Both Auvelity and Wellbutrin are effective for depression but a small RCT (n=80) reported that Auvelity worked significantly better than Wellbutrin and took less time to start working. 43 people prescribed Auvelity experienced an overall decrease in their Montgomery-Åsberg Depression Rating Scale (MADRS) score of 13.7 points after 6 weeks compared to a decrease of 8.8 points in the 37 people prescribed bupropion (least-squares mean difference=-4.9; 95% CI=-3.1, -6.8). Continue reading

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords